Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#385 of 589

Andrew Mok

Barclays · Equity Research Analyst
ProvisionalRating since 2024No new ratings since Nov 2025

Analyst rating accuracy & track record

Andrew Mok is an equity research analyst at Barclays. Quantellect has scored 26 of their stock calls across 11 companies. Their picks beat their sector 39% of the time over the next 12 months, and their price targets were reached 57% of the time within a year.

Win % vs sector
39%
PT Hit % (12mo)
57%
Avg sector-excess
−9.3%
Scored calls
26
Tickers
11
Tier
Provisional

Track record

Quantellect has scored 26 of Andrew Mok's stock calls across 11 companies, dating back to 2024. Their rated stocks beat their own sector 39% of the time over the next 12 months. On a typical call, a Mok pick returned −9.3% more than its sector over the following year.

Of the scored calls, 19 were bullish (Buy) and 7 were bearish (Sell). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
RDNTRadNet Inc
Buy$86.00Nov 2025−23.7%Miss
BKDBrookdale Senior Living Inc
Buy$14.00Nov 2025−37.0%Hit
ADUSAddus HomeCare Corporation
Sell$117.00Nov 2025+24.6%Hit
CIThe Cigna Group
Buy$300.00Nov 2025−15.0%Hit
EHCEncompass Health Corp
Buy$150.00Oct 2025−9.4%Miss
UHSUniversal Health Services Inc
Buy$263.00Oct 2025−49.3%Miss
MOHMolina Healthcare Inc
Sell$144.00Oct 2025−2.8%Hit
ELVElevance Health Inc
Buy$385.00Oct 2025+4.9%Hit
UHSUniversal Health Services Inc
Buy$250.00Sep 2025−29.9%Miss
CIThe Cigna Group
Buy$383.00Sep 2025−32.9%Miss
RDNTRadNet Inc
Buy$79.00Sep 2025−24.5%Hit
ADUSAddus HomeCare Corporation
Sell$109.00Aug 2025+24.9%Hit
AVAHAveanna Healthcare Holdings Inc
Buy$9.50Aug 2025+53.3%Hit
AGLagilon health Inc
Sell$1.50Aug 2025−267.8%Hit
UHSUniversal Health Services Inc
Buy$259.00Jul 2025−28.6%Miss
AGLagilon health Inc
Sell$3.00May 2025+35.0%Hit
EHCEncompass Health Corp
Buy$129.00Apr 2025−17.3%Miss
RDNTRadNet Inc
Buy$60.00Mar 2025+16.6%Hit
ALHCAlignment Healthcare LLC
Sell$9.00Feb 2025−18.8%Miss
EHCEncompass Health Corp
Buy$118.00Feb 2025−0.4%Hit
RDNTRadNet Inc
Buy$74.00Jan 2025+0.6%Hit
RDNTRadNet Inc
Buy$85.00Dec 2024−5.5%Hit
ALHCAlignment Healthcare LLC
Sell$8.00Oct 2024−38.1%Miss
EHCEncompass Health Corp
Buy$116.00Oct 2024+25.8%Hit
RDNTRadNet Inc
Buy$79.00Sep 2024+27.9%Hit
Prev1
Go to

Andrew Mok: analyst track record FAQ

Is Andrew Mok a good stock analyst?

Yes, by track record. Andrew Mok ranks number 385 of 589 of the analysts Quantellect scores, with an Analyst Score of 22 out of 100. Past results do not guarantee future ones.

What is Andrew Mok's win rate?

Andrew Mok's win rate is 39%. Across 26 scored calls, their rated stocks beat their sector 39% of the time over the next 12 months. On a typical call they returned −9.3% more than the sector.

What stocks and sectors does Andrew Mok cover?

Andrew Mok covers 11 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Andrew Mok's price targets accurate?

Andrew Mok's price targets are reached within 12 months 57% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Andrew Mok's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Andrew Mok rank among Wall Street analysts?

Andrew Mok ranks number 385 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.